Purpose: Significant challenges exist for Ketogenic Diet (KD) programs in many populations, mainly due to the variations in local dietary preferences. Here we report a single center experience of KD therapy in a cohort of South Indian children with pharmaco-resistant epilepsies. Methods: Children aged 0-18 years, enrolled in the KD program for pharmacoresistant epilepsies of Amrita institute of Medical Sciences, Kochi, Kerala, India (2010 À 2015 were included in this pragmatic study. Diet efficacy was evaluated according to reduction in seizure frequency and in the number of antiepileptic drugs (AED). Duration of retention, reasons for discontinuation and the rate of adverse events were used for assessing KD tolerability. Results: Seventy four children were enrolled in the KD program. Four children could not complete the initiation process. Median age at KD initiation was 4.2years. 53 children had developmental delay. 89% were on 3 or more AEDs. Baseline seizure frequency was >5/day in 52 children. KD was continued for a median duration of 10.43 months. At the last contact, 59.4% reported seizure reduction of more than 50%. More than 90% reduction was noted in 25 children (33.7%). 6(8.1%) of them became completely seizure free. Four children expired during the study period and four children reported major adverse events necessitating KD withdrawal. Main reasons for discontinuation of KD were poor compliance, lack of response to diet and relapse of seizures. Conclusion: KD may be a safe and effective option for children with pharmacoresistant epilepsies even while on a traditional carbohydrate rich South Indian diet.
Introduction
Ketogenic diet (KD) is a medically supervised high fat, low carbohydrate, and moderate-protein diet, which has been used successfully in patients with pharmaco-resistant epilepsy [1, 2] . The classic KD contains a very high amount of fat, with fat to combined protein and carbohydrate ratio being 3-4:1. The fat in KD consists of mainly long chain triglycerides (LCT) and medium chain triglycerides (MCT). The classical KD provides 75%-80% of the recommended daily allowance (RDA) of calories from fat, compared to normal diet in which fat usually provide 20-35% and carbohydrate 50-70% of required calories [3, 4] .
Based upon the available evidence, an international consensus has been published in 2009, recommending the use of ketogenic diet in children with epilepsy refractory to at least two antiepileptic drugs [5] . Even though the efficacy of KD is fairly well established in the management of drug resistant epilepsy in children, it is still being restricted to a few selected centres across the globe [6] . Many factors contribute to this scenario. Along with a lack of awareness among the physicians and caregivers, dearth of trained manpower and dedicated programs remains as the major road block.
The initiation and maintenance of KD is relatively well accepted in children on a typical western diet, which inherently has a high fat: carbohydrate ratio. However, modification of the diet to suit the local dietary preferences is a major challenge [7] . In many countries in Asia, there is a cultural tendency towards carbohydrate rich foods with high glycemic index such as rice as the primary source of energy, especially in children. The typical composition of classical KD in comparison to that of regular western, North Indian and South Indian diets (B, C, D) on the calorie scale is given in Fig. 1 . Even in the same country, there might be regional variations in the dietary preferences. Traditional meals like the typical South Indian diet usually include a stable combination of fish and vegetables along with high quantities of rice. As a result, dietary substitutions for KD therapy are relatively difficult.
The aim of the study was to describe the experience of introduction and maintenance of KD therapy in a cohort of South Indian children with resistant epilepsies, who were on a traditionally carbohydrate rich, rice based diet.
Methods
Children up to the age of eighteen years with refractory epilepsy as per the ILAE definition [8] were initiated on the ketogenic diet program of a tertiary care teaching hospital in Kerala, India, according to a pragmatic institutional protocol. The enrolment period was August 2010 to September 2015. Children with suspected neuro-metabolic disorders were excluded. The clinical data was extracted by retrospective chart review after the necessary approvals from the hospital ethics committee (final approval for publication was obtained on 29/02/2016).
Institutional Protocol: The demographic and clinical profile, investigations, syndromic diagnosis, seizure frequency and the number of AEDs were recorded before the initiation of KD. The KD was initiated in all patients based on the international consensus recommendations with dietary fat to combined carbohydrate and protein ratio ranging from 2:1 to 4:1 [5] . All the children and their families had an interview with the dietician prior to the initiation of KD, during which, the dietary habits and preferences of the child were noted and the strategies to customize the diet were planned. All of them underwent nutritional assessments and baseline laboratory workup including complete blood count, C reactive protein(CRP), electrolytes including calcium, magnesium, phosphate, liver and renal function tests, serum uric acid levels, ammonia and lactate, fasting lipid profile, fasting blood glucose level and urinalysis.
KD was initiated on an inpatient basis following an initial fasting state of 18-20 hours with close monitoring of blood sugar and urine ketones. Then the diet was introduced and escalated depending on the tolerability. During the initiation phase, blood sugars were monitored 6th hourly using the glucometer (Accuchek performa,Roche India) and urine ketones monitored with keto-sticks (Keto-Diastix Reagent Strips for Urinalysis, Bayer 2883B) 8th hourly. Full diet was initiated stepwise over three days and if the child was tolerating he/she was observed for 2-3 days for tolerability and side effects, then was discharged with advice to monitor sugars and urine ketones twice daily at home in the initial weeks. Only urine ketones were monitored twice daily after the first review. For those with urine ketones 2+ or more, once a day monitoring was suggested and others were advised twice daily monitoring. Blood sugars were not routinely monitored after the first review, but parents were advised monitoring especially during illness, when the food intake was reduced or if the child became symptomatic. Patients were given multivitamin supplements along with the diet.
Parents were instructed to keep a seizure diary, blood sugar and urine ketone monitoring charts which were assessed during the follow up visits. The parents were advised about the diet and the recipes. Coconut oil was predominantly used as the fat source. The family was encouraged to use the specified amount of oil in the cooking media or to add it separately with the diet. All the patients had regular follow up in the diet clinic with clinical and laboratory evaluations monthly for first 3months, then 2monthly for 6months, and every 3 months thereafter.
The AED therapy was maintained and modified according to the clinical response as preferred by the treating physician. The seizure frequency, severity and adverse events were recorded by the care givers on a standardized home based seizure diary. The seizure frequencies during the follow-up visits as well as on the last follow-up were recorded separately. All the families had telephonic access to the medical social worker and dietician throughout the initiation and maintenance phase of the ketogenic diet. Diet efficacy was evaluated according to the reduction in the seizure frequency and reduction in the number of antiepileptic drugs (AED). A responder was arbitrarily defined as having a reduction of more than 50% in the baseline seizure frequency.
Seizure reduction was stratified into five levels: complete seizure freedom (level 5), reduction of more than 90% (level 4); reduction of 50 to 90% (level 3); reduction of less than 50% (level 2) and no seizure reduction (level 1) as per already published criterion [8, 9] . Diet tolerability was evaluated based on diet duration, reasons for discontinuation and documented adverse events.
Data were analysed using SPSS-16 software. Categorical variables were described using frequency and percentages and continuous variables were described using mean, median and standard deviation. Univariate analysis was done using chi square and t-test on children who completed the KD initiation process.
Results
Seventy four children were worked up for initiation of KD during the study period. Four of them could not complete the initiation process due to perceived intolerance or development of metabolic derangements such as recurrent hypoglycemia (n = 2), persistent hyperammonemia (n = 1) and recurrent vomiting and diarrhoea (1) . The remaining seventy children completed the initiation process.
The study sample included 48 males and 26 females (M: F ratio-1.84:1). The median age of onset of epilepsy was 18months (range 1month to 13years). Thirty one children reported neonatal seizures. More than one seizure type at initiation of KD were noted in 51 (68.9%) children. 53(71.6%) children reported intellectual disability or developmental delay at baseline. Most of the children (89%) were on 3 or more antiepileptic drugs at the time of initiation of KD. Two children were on single AED and they were diagnosed to have Glucose transporter -1(GLUT-1) deficiency syndrome and six were on 2 AEDs and were having daily seizures. Baseline seizure frequency was >5/day in 52(70.2%) children. Baseline characteristics of patients on initiation of KD are given in Table 1 .
The mean age of KD introduction was 6.16years with median age being 4 year 2 months (range 1month to 17.5 years). The distribution of children based on age at initiation of diet is given in Fig. 2 . Four children were less than 1 year (1m, 4m, 7m, 11m) at the time of initiation of diet. Youngest one was of one month of age. She presented with resistant migratory partial seizures of infancy due to a probable GLUT-1 deficiency syndrome. For her, breast feeding was stopped and formula feeds (Ketokid, British Biologicals, Bangalore, India), which were specially designed for ketogenic diet, was started. Breast feeding was stopped in all the other children. Blendarised millets (suji, ragi) were also initiated as weaning food for children after 4 months of age.
KD was initiated under inpatient care with prior fasting for 18-20 hours in fifty six patients. Most of the patients (n = 67) took KD in 3:1 ratio and the remaining three at 4:1 ratio. Sixteen children were on nasogastric feeds at the time of initiation. None was on gastrostomy feeds at initiation, but one patient was changed to gastrostomy feeds following development of aspiration pneumonia.
Ketogenic diet was continued for a mean duration of 10.43 months (range-1 m to 3yr8months).Patients were followed up for a mean duration of 14.61 months (range-1month to 46months). Four children expired during the study period (two with refractory status epilepticus, one with Epilepsia partialis continua (EPC), one with early infantile epileptic encephalopathy). Two of these four died in the initial month itself. Three children were lost to follow up after one month of initiation. Fifty four of seventy were on KD at 3 months of follow up. Forty five children were on KD at 6 months, 30 children at 1 year, 17 children at 1.5 years. Fifteen patients continued the diet for more than 18 months after the initiation (Table 2) .
Forty four children reported seizure reduction of more than 50% at the last follow up visit. Among these, nineteen children reported seizure reduction between 50 and 90% and 25 children (33.7%), more than 90%. Six children (8.1%) became completely seizure free during the maintenance phase, one each after 1month, 3months, 6months and one year of initiation, and two children after 4 months of diet initiation. They remained seizure free for 6months, 1year, 2.5years, 1.5years and 3years respectively during the maintainance phase. Fig. 3 depicts the seizure outcome of those who were on KD at different follow up periods and it clearly depicts that those who had good response to KD continued the diet for longer periods. Of the 54 patients with 3month follow-up data, 43 (79.6%) were responders and eight became seizure free. At 6months follow up, 37 (82%) out of 45 were responders. Of the 30 who were on KD at 1year, 26children had more than 50% reduction in seizures. Univariate analysis was attempted using the data of patients who completed the initiation of diet (n = 70), to find out any association between the major baseline variables and the seizure outcome. There was no significant association between the outcome and the baseline variables. However, continuation of the diet was noted to be significantly associated with the seizure outcome at different follow up periods (p value <0.001). Table 3 shows the details of the univariate analysis. Table 4 shows the response to KD according to the initial diagnosis and electroclinical syndromes. The absolute numbers were small in the individual groups, hence comparison between the groups was not attempted.
Concomitant AED therapy was not standardized and was left to the discretion of the treating physician. The number of AEDs were reduced in six children during the follow up period. Three patients had reduction of two AEDs. Three AEDs were tapered in one patient and all the AEDs were stopped completely in another one. Fifteen children became noncompliant on the diet during the maintenance period, irrespective of the seizure outcome. The major reasons for discontinuation of the diet were poor compliance, lack of response to the diet as well as relapse of seizure after the initial control. Antiepileptic drugs were modified in children with poor compliance and poor response to KD (n = 19). AEDs were added in 7 children and dosage was hiked up in 12 during the maintenance period.
Both the major and minor adverse events occurred during the initiation and maintenance phase of KD. The major adverse events were either life threatening or which needed discontinuation of diet. The major adverse events were severe diarrhoea (2), lipoid pneumonia(2), recurrent hypoglycemia(3) and persistent hyperammonemia (1) . During the initiation of diet, 12 children had minor events like hypoglycemia, vomiting and loose stools which were managed appropriately and the diet initiation was continued. Four children were not able to complete the initiation process due to major adverse events. During the maintenance phase, KD was terminated in four children. Lipoid pneumonia was the major adverse event of KD during the maintenance phase, which resulted in prolonged ICU care for two children. One child, with recurrent aspiration pneumonia, underwent gastrostomy during the maintenance phase. The minor adverse events noted were diarrhoea and vomiting (7), renal calculi (1), constipation (4), aspiration pneumonia(1).
Discussion
In this study, we evaluated the efficacy and tolerability of ketogenic diet in a series of 74 South Indian children with refractory epilepsy over a period of 5 years. Approximately, one of ten patients (8.4%) became seizure free on KD, while six of ten (61.4%) patients reported a seizure reduction of more than 50%. Our results are comparable with previously published cohorts. Thammongkol et al reported a responder rate of 48% [1] while it was 38% in another RCT from United Kingdom [10] . Similarly, a systematic review reported complete cessation of seizures in 16% of children, greater than 90% reduction in 32%, and greater than 50% reduction in 56% with the use of KD [11] . In a relatively small cohort of children from North India (Sharma et al) [12] , nearly half of 27 children with refractory epilepsy responded to the KD with 50% reduction in seizures. In 15% of children in this cohort, seizure freedom was attained at 6months. Nathan et al reported more than 50% decrease in seizure frequency in 72% of patients [7] . In our study, 82.2% of children who were on the diet at 6months and 86% at 12 months were responders. However intention to treat analysis showed responder rate of 50% and 34% at 6 and 12 months. Another systematic review by Keene et al. [13] including 972 cases, reported an overall response of 33%. Seizure freedom was noted in 15.6% of children at 6 months follow up.
We analysed the outcome based on epilepsy etiologies and electroclinical syndromes. However, the absolute numbers were too small in each category to make any meaningful comparison. Over all, good response was noted for GLUT1 deficiency, Dravet syndrome, Doose syndrome and Lennox Gastaut Syndrome. Response was rather poor for early onset infantile epileptic encephalopathies of probable genetic origin.
The retention rate of this study was comparable to other previous studies. 60.8% and 40.8% of patients were continuing KD at 6months and 12 months respectively. In addition, there was a statistically significant association between the rate of retention and the seizure outome (Table 3) . Freeman et al. [14] have reported a retention rate of 71% and 55% at 6 and 12 months. An Australian prospective study has reported a higher retention rate of 85.9% at 12 months [1] . Indian study by Sharma et al has reported a retention rate of 55% at 6 months and 37% at 12months [12] .
In our study, ketogenic diet was having good tolerability. The serious adverse effects observed during the maintenance phase were lipoid pneumonia and severe hypoglycemia, necessitating the withdrawal of the diet. Other major reasons for discontinuation of the diet were poor compliance, relapse of seizure after initial control or the complete lack of response to diet. As the administration of diet requires a lot of parental efforts, the continuation of the diet is very closely linked to the favourable response to the diet. When the KD was effective in controlling the seizures, families preferred to stay on the diet, even in the presence of minor adverse events. However, they opted out of the diet earlier if the seizure control was much less than their expectations. 86% of the children who continued on the diet at 12months were having more than 50% seizure reduction (Fig. 3) .
It is important to remember that the efficacy and adherence to the diet depend upon the implementation of an institutional multi-disciplinary protocol with robust support of full time dieticians. Regular follow up with multidisciplinary monitoring of these children and their families are needed for ensuring compliance and also for evaluating the efficacy and tolerability. Close parental contacts are also very important for adjusting the diet as well as for the early identification and correction of the adverse effects.
This study clearly point out that the successful introduction of KD therapy in any population needs a lot of customization to suit the local cultural and dietary preferences. As the usual South Indian diet is very rich in carbohydrates, the severe restriction of carbohydrate, especially rice, makes the diet unpalatable and poses a major challenge for the long term maintenance of diet. This lack of cultural acceptability played a major role, especially when the seizure response was also far less than anticipated. However, the traditional South Indian, especially Kerala diet includes a significant amount of fish products and this might have helped in the successful implementation of diet in this cohort. Coconut oil is the traditional cooking medium in this part of the world, which contains more medium chain triglycerides (MCT) compared to other vegetable oils. This might also have contributed to the cultural acceptability of the KD therapy in this population. Less restrictive diets like LGIT or MAD customized to local culinary preferences may be another alternative approach. Further studies are needed to comment upon the efficacy and acceptability of these less restrictive diets in this geographic region.
Strength and limitations of the study
The major strength of our program is the pragmatic design and protocol which provides the therapeutic outcome of KD therapy in real life clinical settings. However, the less rigid nature of such a protocol regarding the urine ketone monitoring and concomitant AED therapy might have surely affected the strength of the observations in this cohort. Concomitant AED therapy was not controlled during the study period and was left to the discretion of the treating physician. In this protocol, seizure outcome was primarily used as the basis for the titration of KD. Diet was up titrated based on urine ketones, only if the seizure control was less than optimal. Hence a proper statistical analysis of the outcome based on urine ketone status was not possible, making it another limitation of this pragmatic design. The absolute numbers in different age groups and epileptic syndromes were too small to make any meaningful comparison. Retrospective nature of the data extraction might also have affected the results of this study.
Conclusion
The present study shows that ketogenic diet may be instituted and effectively maintained long term in children with severe refractory epilepsies even in populations who are used to the intake of a high glycemic index carbohydrate rich diet. This pragmatic protocol may be considered to be much closer to the standard clinical practice in this part of the world and the results of this study may be taken as a real life validation of the therapeutic outcome of KD. Along with the development of major multicentric prospective KD registries looking at the efficacy and acceptability across various epileptic syndromes and etiological entities, the institution of strategies for long term maintenance of the different types of diets across populations with varied culinary practices may also help in firmly establishing the role of dietary therapy in resistant childhood epilepsies.
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